Tag fda [60 articles] Export

Recent papers classified by the tag fda.

	Core Shape modelling of a set of curves [My Copy] Computational Statistics & Data Analysis (14 August 2009) by S. Boudaoud, H. Rix, O. Meste posted to statistics fda by Gorzomagnificent on 2009-10-25 12:48:22 as
	Host cell proteins in biologics development: Identification, quantitation and risk assessment [My Copy] Biotechnology and Bioengineering, Vol. 103, No. 3. (2009), pp. 446-458. by Xing Wang, Alan K. Hunter, Ned M. Mozier posted to guidance fda by klabs on 2009-10-17 08:51:41 as
	Optimal and consistent protein glycosylation in mammalian cell culture [My Copy] Glycobiology, Vol. 19, No. 9. (1 September 2009), pp. 936-949. by Patrick Hossler, Sarwat F. Khattak, Zheng J. Li posted to guidance fda by klabs on 2009-10-17 08:38:30 as
	Balancing Innovation and Access: Patent Challenges Tip the Scales [My Copy] Science, Vol. 326, No. 5951. (16 October 2009), pp. 370-371. by Matthew J. Higgins, Stuart J. H. Graham posted to us patents innovation fda balancing access by jago to the group Patent_Reform on 2009-10-16 07:31:23 as along with 2 groups Integrative Expertise for Global Health Convention on Knowledge Commons
	The impact of FDA guidance on pharmacogenomic data submissions on drug development. [My Copy] IDrugs : the investigational drugs journal, Vol. 8, No. 8. (August 2005), pp. 648-650. by Stephen Little posted to pharmacogenetics guideline fda drug_discovery by misonneh on 2009-10-12 22:36:59 as
	4th US FDA-Drug Information Association pharmacogenomics workshop, held 10-12 December, 2007. [My Copy] Pharmacogenomics, Vol. 10, No. 1. (January 2009), pp. 111-115. by Felix W. Frueh, Ronald A. Salerno, Lawrence J. Lesko, Richard D. Hockett posted to summary pharmacogenomics guideline fda by misonneh on 2009-09-29 18:36:31 as
	Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use. [My Copy] Pharmacotherapy, Vol. 28, No. 8. (August 2008), pp. 992-998. by Felix W. Frueh, Shashi Amur, Padmaja Mummaneni, et al.Robert S. Epstein, Ronald E. Aubert, Teresa M. DeLuca, Robert R. Verbrugge, Gilbert J. Burckart, Lawrence J. Lesko posted to summary pharmacogenetics fda biomarker by misonneh on 2009-09-29 18:31:30 as
	Personalized medicine: elusive dream or imminent reality? [My Copy] Clinical pharmacology and therapeutics, Vol. 81, No. 6. (June 2007), pp. 807-816. by L. J. Lesko posted to review pharmacogenetics fda comments by misonneh on 2009-09-29 18:29:20 as along with 2 people junbo_yin PredictER
	Regulatory perspective on the importance of ADME assessment of nanoscale material containing drugs☆☆☆ [My Copy] Advanced Drug Delivery Reviews, Vol. 61, No. 6. (21 June 2009), pp. 422-427. by Banu S. Zolnik, Nakissa Sadrieh posted to regulatory_issues regulatory nanoparticles nanomedicine liposome fda drug_delivery by monkare on 2009-09-23 21:34:32 as
	Market watch: Sales trends by therapeutic area: 2008\|[ndash]\|2013E [My Copy] Nat Rev Drug Discov, Vol. 8, No. 9. (01 September 2009), pp. 689-689. by Michael Goodman posted to market_watch fda by monkare on 2009-09-22 14:43:28 as
	Network analysis of FDA approved drugs and their targets. [My Copy] The Mount Sinai journal of medicine, New York, Vol. 74, No. 1. (April 2007), pp. 27-32. by Avi Ma'ayan, Sherry L. Jenkins, Joseph Goldfarb, Ravi Iyengar posted to network fda drug discovery cheminformatics by egonw on 2009-09-21 07:53:54 as along with 2 people and 1 group guhjy raiyar steinmetzlab
	Curve forecasting by functional autoregression [My Copy] Journal of Multivariate Analysis, Vol. 99, No. 10. (November 2008), pp. 2508-2526. by V. Kargin, A. Onatski posted to autoregressive fda by yairgo on 2009-07-02 13:54:50 as
	Forecasting Time Series By Functional PCA. Discussion Of Several Weighted Approaches [My Copy] Social Science Research Network Working Paper Series (09 December 1999) by Ana M. Aguilera Del Pino, Francisco A. Ocaña, Mariano J. Valderrama posted to autoregressive fda by yairgo on 2009-07-02 13:33:22 as
	A functional waveletkernel approach for time series prediction [My Copy] Journal of the Royal Statistical Society: Series B (Statistical Methodology), Vol. 68, No. 5. (November 2006), pp. 837-857. by Anestis Antoniadis, Efstathios Paparoditis, Theofanis Sapatinas posted to autoregressive fda by yairgo on 2009-07-02 12:39:29 as
	Robust forecasting of mortality and fertility rates: A functional data approach [My Copy] Computational Statistics & Data Analysis, Vol. 51, No. 10. (15 June 2007), pp. 4942-4956. by R. Hyndman, M. Shahidullah posted to autoregressive fda by yairgo on 2009-07-02 12:23:53 as
	An exact confidence band for one-dimensional polynomial regression [My Copy] Biometrika, Vol. 71, No. 2. (1 August 1984), pp. 375-379. by H. P. Wynn posted to confidence_band fda by yairgo on 2009-06-28 07:14:00 as
	FDA Regulation of Stem Cell-Based Products [My Copy] Science, Vol. 324, No. 5935. (26 June 2009), pp. 1662-1663. by Donald W. Fink posted to clinicaltrials fda multi-level regulation risk stem-cell usa by jago to the group Convention on Knowledge Commons on 2009-06-26 09:26:58 as along with 1 group Integrative Expertise for Global Health
	Confidence Bands for Regression Functions [My Copy] Journal of the American Statistical Association, Vol. 80, No. 391. (1985), pp. 683-691. by George Knafl, Jerome Sacks, Donald Ylvisaker posted to confidence_band fda by yairgo on 2009-06-25 11:07:04 as
	Confidence Bands in Nonparametric Regression [My Copy] Journal of the American Statistical Association, Vol. 88, No. 424. (1993), pp. 1287-1301. by R. L. Eubank, P. L. Speckman posted to confidence_band fda by yairgo on 2009-06-25 11:04:27 as
	Nonparametric Estimation of Common Regressors for Similar Curve Data [My Copy] The Annals of Statistics, Vol. 22, No. 3. (1994), pp. 1386-1427. by Alois Kneip posted to fda by yairgo on 2009-06-16 09:59:29 as
	Estimating the Mean and Covariance Structure Nonparametrically When the Data are Curves [My Copy] Journal of the Royal Statistical Society. Series B (Methodological), Vol. 53, No. 1. (1991), pp. 233-243. by John A. Rice, B. W. Silverman posted to fda by yairgo on 2009-06-16 09:54:49 as
	Simultaneous non-parametric regressions of unbalanced longitudinal data [My Copy] Computational Statistics & Data Analysis, Vol. 24, No. 3. (12 May 1997), pp. 255-270. by P. Besse posted to fda by yairgo on 2009-06-14 09:23:29 as
	The Sparse Eigenvalue Problem [My Copy] (12 Jan 2009) by Bharath Sriperumbudur, David Torres, Gert Lanckriet posted to cca cross_language_document_retrieval dc_program fda generalized_eigenvalue_problem global_convergence_analysis majorization_minimization music_annotation pca by markstoehr to the group Statistical Machine Learning on 2009-05-27 01:17:07 as
	Evaluating Co-primary Endpoints Collectively in Clinical Trials. [My Copy] Biometrical journal. Biometrische Zeitschrift, Vol. 51, No. 1. (13 February 2009), pp. 137-145. by Qian H H. Li posted to 2009 coprimary fda multiple-endpoints by Prlwrlczkwsky on 2009-05-18 17:01:16 as along with 1 person guhjy
	The Factorized Distribution Algorithm and the Minimum Relative Entropy Principle [My Copy] Scalable Optimization via Probabilistic Modeling (2006), pp. 11-37. by Heinz Mühlenbein, Robin Höns posted to eda entropy factorization fda mre by kuaaaaa on 2009-05-14 06:26:17 as
	Playing "Kick the FDA" -- Risk-free to Players but Hazardous to Public Health [My Copy] N Engl J Med, Vol. 358, No. 17. (24 April 2008), pp. 1774-1775. by Alastair J. Wood posted to fda by NCCNHealthPolicyGroup on 2009-05-13 18:36:18 as
	Does the FDA have the authority to trump the Declaration of Helsinki? [My Copy] BMJ, Vol. 338, No. apr21_1. (21 April 2009), b1559. by Michael D. Goodyear, Trudo Lemmens, Dominique Sprumont, Godfrey Tangwa posted to ethics fda by plosmedicine on 2009-05-07 13:17:41 as
	Robust functional estimation using the median and spherical principal components [My Copy] Biometrika, Vol. 95, No. 3. (1 September 2008), pp. 587-600. by Daniel Gervini posted to fda by yairgo on 2009-05-07 03:05:17 as
	CAN THE PHARMACEUTICAL INDUSTRY REDUCE ATTRITION RATES? [My Copy] Nat Rev Drug Discov, Vol. 3, No. 8. (2004), pp. 711-716. by Ismail Kola, John Landis posted to attrition fda by ph on 2009-04-30 19:07:26 as along with 2 people tbinbal qfwills
	2008 FDA drug approvals [My Copy] Nat Rev Drug Discov, Vol. 8, No. 2. (01 February 2009), pp. 93-96. by Bethan Hughes posted to fda review by monkare on 2009-03-03 15:23:27 as
	Biomarker debate highlights retrospective challenge [My Copy] Nat Rev Drug Discov, Vol. 8, No. 3. (March 2009), pp. 179-180. by Dan Jones posted to biomarkers cancer fda news by wimufi on 2009-02-27 17:47:50 as
	Helsinki discords: FDA, ethics, and international drug trials. [My Copy] Lancet, Vol. 373, No. 9657. (3 January 2009), pp. 13-14. by J. Kimmelman, C. Weijer, E. M. Meslin posted to fda helsinki international-research research-ethics by PredictER on 2009-02-05 00:48:32 as along with 1 person cntbioet
	Pharmacogenetics: improving drug and dose selection [My Copy] Current Opinion in Pharmacology, Vol. 8, No. 5. (October 2008), pp. 639-646. by A. Bhathena, B. Spear posted to cyp2c9 fda genetics pharmacogenetics review tpmt ugt1a1 by misonneh on 2009-01-19 05:07:54 as along with 1 person zimbo1
	Structuralism, post-structuralism, neo-liberalism: assessing Foucault's legacy [My Copy] Journal of Education Policy, Vol. 18, No. 2. (2003), pp. 189-202. by Mark Olssen posted to fda foucault neo-liberalism post-structuralism social structuralism theory by LynneL on 2009-01-11 11:40:57 as
	'The birth of bio-politics': Michel Foucault's lecture at the Collège de France on neo-liberal governmentality [My Copy] Economy and Society, Vol. 30, No. 2. (2001), pp. 190-207. by Thomas Lemke posted to bio-politics fda foucault governmentality neo-liberalism by LynneL on 2009-01-11 10:55:22 as
	Functional Data Analysis Applied to a Randomized Controlled Clinical Trial in Hemodialysis Patients Describes the Variability of Patient Responses in the Control of Renal Anemia [My Copy] J Am Soc Nephrol, Vol. 18, No. 8. (1 August 2007), pp. 2371-2376. by Robert M. West, Katie Harris, Mark S. Gilthorpe, Cae Tolman, Eric J. Will posted to fda renal by minrmw on 2008-12-30 18:30:46 as along with 1 person guhjy
	Interday Forecasting and Intraday Updating of Call Center Arrivals [My Copy] MANUFACTURING SERVICE OPERATIONS MANAGEMENT, Vol. 10, No. 3. (1 June 2008), pp. 391-410. by Haipeng Shen, Jianhua Z. Huang posted to fda forecasting by yairgo on 2008-12-04 22:23:37 as
	Functional Data Analysis [My Copy] (08 June 2005) by J. O. Ramsay, B. W. Silverman posted to fda statistics by amsantos on 2008-11-22 00:35:47 as along with 3 people olberd surajitray brent_lance
	Paving the Critical Path: How can Clinical Pharmacology Help Achieve the Vision? [My Copy] Clinical Pharmacology & Therapeutics, Vol. 81, No. 2. (01 February 2007), pp. 170-177. by L. J. Lesko posted to critical fda path by rwinegar on 2008-11-14 14:55:35 as along with 1 person misonneh
	EFNS guidelines on neuropathic pain assessment [My Copy] European Journal of Neurology, Vol. 11, No. 3. (2004), pp. 153-162. by G. Cruccu, P. Anand, N. Attal, et al.Garcia L. Larrea, M. Haanpaa, E. Jorum, J. Serra, T. S. Jensen posted to fda neuropathic pain by ph on 2008-10-29 17:01:44 as
	FDA to steer nanotech [My Copy] Nature Biotechnology, Vol. 26, No. 10., pp. 1060-1060. by Jeffrey L. Fox posted to drug_delivery fda nanomedicine nanotechnology regulation bionano by alexknight on 2008-10-13 11:50:27 as along with 1 person Scis0000002
	Leave Regulation to the FDA [My Copy] Science, Vol. 321, No. 5888. (25 July 2008), 490a. by Owen C. Hughes posted to fda regulation risk-articulation us by jago to the group Integrative Expertise for Global Health on 2008-08-12 14:52:14 as
	Manufacturing Consensus [My Copy] Culture, Medicine and Psychiatry, Vol. V30, No. 2. (30 June 2006), pp. 135-156. by David Healy posted to clinicaltrials fda problem-articulation science-abuse us by jago on 2008-06-30 23:11:52 as along with 3 people and 2 groups paultr pseudopharm rayoulike Integrative Expertise for Global Health Convention on Knowledge Commons
	FDA Drops Helsinki Rules [My Copy] Science, Vol. 320, No. 5877. (9 May 2008), 731b. by Jennifer Couzin posted to ethics fda pharmaceuticals by kkaplon11 on 2008-05-09 14:49:46 as
	Principal component models for sparse functional data [My Copy] Biometrika, Vol. 87, No. 3. (1 September 2000), pp. 587-602. by G. M. James, T. J. Hastie, C. A. Sugar posted to fda by yairgo on 2008-04-01 07:06:33 as
	Drug-Review Deadlines and Safety Problems [My Copy] N Engl J Med, Vol. 358, No. 13. (27 March 2008), pp. 1354-1361. by Daniel Carpenter, Evan J. Zucker, Jerry Avorn posted to fda registration by cucherat on 2008-03-27 21:09:56 as
	Canonical Correlation Analysis when the Data are Curves [My Copy] by S. E. Leurgans, R. A. Moyeed, B. W. Silverman posted to fda by yairgo on 2008-03-25 08:27:51 as along with 1 person surajitray
	Smoothed Functional Principal Components Analysis by Choice of Norm [My Copy] The Annals of Statistics, Vol. 24, No. 1. (1996), pp. 1-24. by Bernard W. Silverman posted to fda by yairgo on 2008-03-23 09:51:54 as along with 1 person surajitray
	Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration [My Copy] PLoS Med, Vol. 5, No. 2. (26 February 2008), e45. by Irving Kirsch, Brett J. Deacon, Tania B. Huedo-Medina, Alan Scoboria, Thomas J. Moore, Blair T. Johnson posted to analysis depression fda medicine prozac statistics by neils on 2008-02-26 00:29:26 as along with 8 people apgaylard mggoldstein bhengeveld jbhiatt shoshin microserf almostc timsenior
	Graph Embedding and Extensions: A General Framework for Dimensionality Reduction [My Copy] Pattern Analysis and Machine Intelligence, IEEE Transactions on, Vol. 29, No. 1. (2007), pp. 40-51. by Shuicheng Yan, Dong Xu, Benyu Zhang, Hong-Jiang Zhang, Qiang Yang, S. Lin posted to fda manifold-learning metric-learning by jung_dalglish on 2008-02-03 09:13:07 as along with 4 people and 1 group xtizon sdvillal zoop mdreid Statistical Machine Learning

Note: You may cite this page as: http://www.citeulike.org/tag/fda

Result page: 1 2 Next

us	8
regulation	6
access	5
balancing	5
innovation	5
patents	5
autoregressive	4
clinicaltrials	4
pharmacogenetics	4
confidence_band	3
gram-matrix-learning	3
manifold-learning	3
metric-learning	3
multi-level	3
review	3
risk	3
statistics	3
stem-cell	3
usa	3
attrition	2
biobank	2
cca	2
cross_language_document_retrieval	2
dc_program	2
drug_delivery	2
eda-theory	2
edas	2
entropy	2
ethics	2
foucault	2
generalized_eigenvalue_problem	2
global_convergence_analysis	2
guidance	2
guideline	2
helsinki	2
informed-consent	2
majorization_minimization	2
music_annotation	2
nanomedicine	2
neo-liberalism	2
neuropathic	2
pain	2
pca	2
research-ethics	2
risk-articulation	2
summary	2
2009	1
analysis	1
bci	1
bio-politics	1
biomarkers	1
bionano	1
boa	1
cancer	1
cheminformatics	1
comments	1
coprimary	1
critical	1
cyp2c9	1
depression	1
discovery	1
drug	1
eben	1
eda	1
evolutionary-computation	1
forecasting	1
ga-theory	1
genetic-algorithms	1
genetic-programming	1
genetics	1
governmentality	1
graphical-models	1
industry	1
international	1
international-research	1
kernel-method	1
kikuchi-approximations	1
linkage	1
liposome	1
market_watch	1
multiple-endpoints	1
nanoparticles	1
nanotechnology	1
network	1
news	1
openness	1
optimization	1
path	1
pharmaceuticals	1
pharmacogenomics	1
problem-articulation	1
prozac	1
registration	1
renal	1
science-abuse	1
social	1
theory	1
tpmt	1
transparency	1
ugt1a1	1

Tag fda [60 articles] Export

Related Tags